Duration of remission using I-131 tositumomab in patients with B-cell lymphoma relapsing after autologous stem cell transplant. Background: DLBCL with BM involvement is an uncommon condition, and it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results